News

UK-based Intelligent Fingerprinting, developers of the world’s first portable fingerprint drug test, have secured a further £1.7 million of funding from a group of private US and UK investors. The investment will help accelerate commercialisation of the recently launched Intelligent Fingerprinting Drug Screening System.

Life sciences professionals and business development dealmakers from all walks of industry, academia and government have a new interchange at SLAS2018 – SLAS Ignite, a series of programs that foster scientific innovation through collaboration, debuts at the 2018 SLAS International Conference and Exhibition.

A research team have identified a new genetic mutation that alters the function of cryopyrin and leads to a life-long periodic inflammation of the cornea, the transparent window of the human eye. Patients who carry the mutation also develop corneal opacities that compromise vision.

New research has found that women who follow a “Mediterranean” diet in the six months before assisted reproductive treatment have a significantly better chance of becoming pregnant and giving birth to a live baby than women who did not.

An expert panel has updated guidelines describing the genetic tests that should be performed to evaluate a patient's lung cancer.

A test that measures the levels of two types of immune cell in the blood could identify which cancer patients are most likely to respond to immunotherapy.

Scientists have developed a new type of membrane test strip for the quantitative immunochromatographic rapid-test that will be able to accurately and quickly make an early diagnosis of an acute myocardial infarction through the presence of disease markers in blood.

The role of genetics in the risk of having an immune disease could be missed in research, scientists suggest. Using a combination of stem cells and novel analytical tools, scientists discovered that clues to the contribution of genetic variation to disease risk lie not only in the genes, but also in the molecular switches that control those genes.

Findings could help diagnose risk of Alzheimer's Disease earlier.

A study shows that our immune system handles graphene oxide (GO) in a manner similar to pathogens, paving the way for safer biomedical applications of this two-dimensional material.